Live Geos: https://partners.subjectwell.com/publishers/geos_report/9d5ea137-156a-41eb-b4d4-a4f3a5003bec Ages: 18-70 Gender: Any Study Description: This study is testing an investigational medication for Celiac Disease. Participants will receive 3 IV infusions (given directly into your bloodstream through a vein) of either the study medication or a placebo over a one-week timeframe. You will be monitored for 4 hours at the clinic after every infusion. Additional procedures include vital signs, physical exams, ECG, blood and urine collection, daily questionnaires about celiac symptoms, a 14-day gluten challenge and up to 2 upper endoscopies with biopsies. Total participation will last approximately 3 months and would include up to 8 doctor’s visits and 2 phone calls with the site. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic. The clinical staff will need your medical records to confirm your celiac disease diagnosis, including blood tests for positive antibodies (serology tests like TTG IgA or other similar tests) and biopsy findings. Please make sure you have access to these medical records so that the study team can review them. Qualifications: - A physician must have diagnosed you with Celiac disease and it must be confirmed through both a small intestinal biopsy and a blood test - Must have been on a gluten-free diet for one year or longer - Cannot have type I diabetes

ProfitsNXT